Dipeptide-Repeat Vaccine to prevent ALS and FTD in C9orf72 mutation carriers

Project Information

DPR-VAX

Grant agreement ID: 875677

DOI 10.3030/875677

Project closed

EC signature date 10 December 2019

Start date 1 March 2020

End date 31 May 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 0,00

EU contribution € 150 000,00

Coordinated by

DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV
Germany

Publications

Peer reviewed articles (1)

Chronic T cell proliferation in brains after stroke could interfere with the efficacy of immunotherapies.

Author(s): Heindl, Steffanie; Ricci, Alessio; Carofiglio, Olga; Zhou, Qihui; Arzberger, Thomas; Lenart, Nikolett; Franzmeier, Nicolai; Hortobagyi, Tibor; Nelson, Peter T.; Stowe, Ann M.; Denes, Adam; Edbauer, Dieter; Liesz, Arthur
Published in: The Journal of Experimental Medicine, Issue 15409538, 2021, ISSN 1540-9538
Publisher: Rockefeller University Press
DOI: 10.1084/jem.20202411

Intellectual Property Rights

Patent (1)

IMMUNOGEN FOR PREVENTING OR TREATING FAMILIAL FRONTOTEMPORAL DEMENTIA (FTD) AND/OR AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Application/Publication number: 20 20062343
Date: 2020-05-04